Bharat biotech submits phase 3 trial data, expert panel meet today| Covaxin | Oneindia News

Video Credit: Oneindia
Published on June 22, 2021 - Duration: 02:02s

Bharat biotech submits phase 3 trial data, expert panel meet today| Covaxin | Oneindia News

Bharat Biotech has submitted Phase 3 clinical trial data for its Covid-19 vaccine, Covaxin, to the Drug Controller General of India (DCGI).

The development comes nearly five months after Covaxin was authorised for emergency usage in the country.

#Covid19 #BharatBiotech #Covaxin


You are here


💡 newsR Knowledge: Other News Mentions

Bharat Biotech

Indian multinational biotechnology company and vaccine manufacturer

COVID-19

Contagious disease caused by SARS-CoV-2
A 22-year-old cricketer and biotechnology student, Tauseef Ali Farooqui, arrested under UAPA for expressing intent to join IS. Mental health issues during Covid..
Credit: IndiaTimes - Published 12 hours ago

The government will end routine COVID testing for hospital patients discharged into care homes from April 1.
Credit: Sky News - Published 4 days ago

Exactly four years ago today, Boris Johnson announced the UK's first COVID lockdown, ordering people to "stay at home".
Credit: Sky News - Published 1 week ago

Related videos from verified sources

Haryana CM to farmers: We are patient but don't cross limits| Farmer Protest| Oneindia News 02:36
Video credit: Oneindia - Published on June 30, 2021 

Covaxin neutralizes both Alpha & Delta variants of coronavirus: US Institute| Oneindia News 02:11
Video credit: Oneindia - Published on June 30, 2021 

Brazil suspends Covid-19 vaccine deal with India| Bharat Biotech denies any wrongdoing|Oneindia News 02:00
Video credit: Oneindia - Published on June 30, 2021 

You might like